123 related articles for article (PubMed ID: 37793275)
1. Assessment of the PARP inhibitor talazoparib photosafety profile.
Mateos-Pujante A; Jiménez MC; Andreu I
Biomed Pharmacother; 2023 Nov; 167():115593. PubMed ID: 37793275
[TBL] [Abstract][Full Text] [Related]
2. Non-animal photosafety assessment approaches for cosmetics based on the photochemical and photobiochemical properties.
Onoue S; Suzuki G; Kato M; Hirota M; Nishida H; Kitagaki M; Kouzuki H; Yamada S
Toxicol In Vitro; 2013 Dec; 27(8):2316-24. PubMed ID: 24134854
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of phototoxicity induced by the anticancer drug rucaparib.
Mateos-Pujante A; Jiménez MC; Andreu I
Sci Rep; 2022 Mar; 12(1):3434. PubMed ID: 35236893
[TBL] [Abstract][Full Text] [Related]
4. The PARP inhibitor PJ-34 sensitizes cells to UVA-induced phototoxicity by a PARP independent mechanism.
Lakatos P; Hegedűs C; Salazar Ayestarán N; Juarranz Á; Kövér KE; Szabó É; Virág L
Mutat Res; 2016 Aug; 790():31-40. PubMed ID: 27427773
[TBL] [Abstract][Full Text] [Related]
5. Non-animal photosafety screening for complex cosmetic ingredients with photochemical and photobiochemical assessment tools.
Nishida H; Hirota M; Seto Y; Suzuki G; Kato M; Kitagaki M; Sugiyama M; Kouzuki H; Onoue S
Regul Toxicol Pharmacol; 2015 Aug; 72(3):578-85. PubMed ID: 26048216
[TBL] [Abstract][Full Text] [Related]
6. A Very Long-Acting PARP Inhibitor Suppresses Cancer Cell Growth in DNA Repair-Deficient Tumor Models.
Fontaine SD; Ashley GW; Houghton PJ; Kurmasheva RT; Diolaiti M; Ashworth A; Peer CJ; Nguyen R; Figg WD; Beckford-Vera DR; Santi DV
Cancer Res; 2021 Feb; 81(4):1076-1086. PubMed ID: 33323380
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of chemical photoreactivity and the relationship to phototoxicity.
Kleinman MH; Smith MD; Kurali E; Kleinpeter S; Jiang K; Zhang Y; Kennedy-Gabb SA; Lynch AM; Geddes CD
Regul Toxicol Pharmacol; 2010 Nov; 58(2):224-32. PubMed ID: 20600453
[TBL] [Abstract][Full Text] [Related]
8. Sustained, local delivery of the PARP inhibitor talazoparib prevents the development of mammary gland hyperplasia in Brca1-deficient mice.
Zhang D; Singh B; Moerland J; Mitchell O; Lockwood L; Carapellucci S; Sridhar S; Liby KT
Sci Rep; 2021 Jan; 11(1):1234. PubMed ID: 33441637
[TBL] [Abstract][Full Text] [Related]
9. Long-Acting Poly(ADP-ribose) Polymerase Inhibitor Prodrug for Humans.
Carreras CW; Fontaine SD; Reid RR; Ashley GW; Santi DV
Bioconjug Chem; 2024 Apr; 35(4):551-558. PubMed ID: 38591781
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on prediction performance of photosafety testing tools on photoallergens.
Onoue S; Ohtake H; Suzuki G; Seto Y; Nishida H; Hirota M; Ashikaga T; Kouzuki H
Toxicol In Vitro; 2016 Jun; 33():147-52. PubMed ID: 26973152
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates.
Onoue S; Kawamura K; Igarashi N; Zhou Y; Fujikawa M; Yamada H; Tsuda Y; Seto Y; Yamada S
J Pharm Biomed Anal; 2008 Aug; 47(4-5):967-72. PubMed ID: 18455898
[TBL] [Abstract][Full Text] [Related]
12. Development of a new photosafety test method based on singlet oxygen generation detected using electron spin resonance.
Hinoshita M; Abe T; Sato A; Maeda Y; Takeyoshi M
J Appl Toxicol; 2021 Feb; 41(2):247-255. PubMed ID: 32671887
[TBL] [Abstract][Full Text] [Related]
13. Potential phototoxicity of rosuvastatin mediated by its dihydrophenanthrene-like photoproduct.
Nardi G; Lhiaubet-Vallet V; Leandro-Garcia P; Miranda MA
Chem Res Toxicol; 2011 Oct; 24(10):1779-85. PubMed ID: 21923146
[TBL] [Abstract][Full Text] [Related]
14. [Current Issues in Photosafety Evaluation].
Onoue S; Kouzuki H; Toyoda A; Fueki O; Hosoi K; Kojima H; Ashikaga T; Onodera H
Yakugaku Zasshi; 2021; 141(1):111-124. PubMed ID: 33390438
[TBL] [Abstract][Full Text] [Related]
15. In vitro phototoxicity of dihydropyridine derivatives: a photochemical and photobiological study.
Onoue S; Igarashi N; Yamauchi Y; Murase N; Zhou Y; Kojima T; Yamada S; Tsuda Y
Eur J Pharm Sci; 2008 Mar; 33(3):262-70. PubMed ID: 18207709
[TBL] [Abstract][Full Text] [Related]
16. Photosafety screening of phenothiazine derivatives with combined use of photochemical and cassette-dosing pharmacokinetic data.
Onoue S; Kato M; Inoue R; Seto Y; Yamada S
Toxicol Sci; 2014 Feb; 137(2):469-77. PubMed ID: 24241722
[TBL] [Abstract][Full Text] [Related]
17. Review of the performance of the 3T3 NRU in vitro phototoxicity assay in the pharmaceutical industry.
Lynch AM; Wilcox P
Exp Toxicol Pathol; 2011 Mar; 63(3):209-14. PubMed ID: 20060695
[TBL] [Abstract][Full Text] [Related]
18. In vitro photosafety and efficacy screening of apigenin, chrysin and beta-carotene for UVA and VIS protection.
Freitas JV; Gaspar LR
Eur J Pharm Sci; 2016 Jun; 89():146-53. PubMed ID: 27130544
[TBL] [Abstract][Full Text] [Related]
19. Development of an albuminous reactive oxygen species assay for photosafety evaluation under experimental biomimetic conditions.
Onoue S; Kato M; Yamada S
J Appl Toxicol; 2014 Feb; 34(2):158-65. PubMed ID: 23355082
[TBL] [Abstract][Full Text] [Related]
20. The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.
Ceridono M; Tellner P; Bauer D; Barroso J; Alépée N; Corvi R; De Smedt A; Fellows MD; Gibbs NK; Heisler E; Jacobs A; Jirova D; Jones D; Kandárová H; Kasper P; Akunda JK; Krul C; Learn D; Liebsch M; Lynch AM; Muster W; Nakamura K; Nash JF; Pfannenbecker U; Phillips G; Robles C; Rogiers V; Van De Water F; Liminga UW; Vohr HW; Wattrelos O; Woods J; Zuang V; Kreysa J; Wilcox P
Regul Toxicol Pharmacol; 2012 Aug; 63(3):480-8. PubMed ID: 22687423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
